Your browser doesn't support javascript.
loading
Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma.
Xu, Rui-Hua; Wei, Wei; Krawczyk, Michal; Wang, Wenqiu; Luo, Huiyan; Flagg, Ken; Yi, Shaohua; Shi, William; Quan, Qingli; Li, Kang; Zheng, Lianghong; Zhang, Heng; Caughey, Bennett A; Zhao, Qi; Hou, Jiayi; Zhang, Runze; Xu, Yanxin; Cai, Huimin; Li, Gen; Hou, Rui; Zhong, Zheng; Lin, Danni; Fu, Xin; Zhu, Jie; Duan, Yaou; Yu, Meixing; Ying, Binwu; Zhang, Wengeng; Wang, Juan; Zhang, Edward; Zhang, Charlotte; Li, Oulan; Guo, Rongping; Carter, Hannah; Zhu, Jian-Kang; Hao, Xiaoke; Zhang, Kang.
Afiliación
  • Xu RH; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.
  • Wei W; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.
  • Krawczyk M; Moores Cancer Center and Institute for Genomic Medicine, University of California, San Diego, La Jolla, California 92093, USA.
  • Wang W; Moores Cancer Center and Institute for Genomic Medicine, University of California, San Diego, La Jolla, California 92093, USA.
  • Luo H; Moores Cancer Center and Institute for Genomic Medicine, University of California, San Diego, La Jolla, California 92093, USA.
  • Flagg K; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.
  • Yi S; Moores Cancer Center and Institute for Genomic Medicine, University of California, San Diego, La Jolla, California 92093, USA.
  • Shi W; Moores Cancer Center and Institute for Genomic Medicine, University of California, San Diego, La Jolla, California 92093, USA.
  • Quan Q; Moores Cancer Center and Institute for Genomic Medicine, University of California, San Diego, La Jolla, California 92093, USA.
  • Li K; Moores Cancer Center and Institute for Genomic Medicine, University of California, San Diego, La Jolla, California 92093, USA.
  • Zheng L; Molecular Medicine Research Center, West China Hospital, Sichuan University, Chengdu 610041, China.
  • Zhang H; Molecular Medicine Research Center, West China Hospital, Sichuan University, Chengdu 610041, China.
  • Caughey BA; Guangzhou Youze Biological Pharmaceutical Technology Company Ltd., Guangzhou 510005, China.
  • Zhao Q; Shanghai Center for Plant Stress Biology, Shanghai Institute for Biological Sciences, Chinese Academy of Sciences, Shanghai 210602, China.
  • Hou J; Moores Cancer Center and Institute for Genomic Medicine, University of California, San Diego, La Jolla, California 92093, USA.
  • Zhang R; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.
  • Xu Y; Moores Cancer Center and Institute for Genomic Medicine, University of California, San Diego, La Jolla, California 92093, USA.
  • Cai H; Moores Cancer Center and Institute for Genomic Medicine, University of California, San Diego, La Jolla, California 92093, USA.
  • Li G; Molecular Medicine Research Center, West China Hospital, Sichuan University, Chengdu 610041, China.
  • Hou R; Molecular Medicine Research Center, West China Hospital, Sichuan University, Chengdu 610041, China.
  • Zhong Z; Guangzhou Youze Biological Pharmaceutical Technology Company Ltd., Guangzhou 510005, China.
  • Lin D; Molecular Medicine Research Center, West China Hospital, Sichuan University, Chengdu 610041, China.
  • Fu X; Guangzhou Youze Biological Pharmaceutical Technology Company Ltd., Guangzhou 510005, China.
  • Zhu J; Guangzhou Youze Biological Pharmaceutical Technology Company Ltd., Guangzhou 510005, China.
  • Duan Y; Moores Cancer Center and Institute for Genomic Medicine, University of California, San Diego, La Jolla, California 92093, USA.
  • Yu M; Moores Cancer Center and Institute for Genomic Medicine, University of California, San Diego, La Jolla, California 92093, USA.
  • Ying B; Moores Cancer Center and Institute for Genomic Medicine, University of California, San Diego, La Jolla, California 92093, USA.
  • Zhang W; Moores Cancer Center and Institute for Genomic Medicine, University of California, San Diego, La Jolla, California 92093, USA.
  • Wang J; Moores Cancer Center and Institute for Genomic Medicine, University of California, San Diego, La Jolla, California 92093, USA.
  • Zhang E; Molecular Medicine Research Center, West China Hospital, Sichuan University, Chengdu 610041, China.
  • Zhang C; Department of Clinical Laboratory Medicine, West China Hospital, Sichuan University, Chengdu 610041, China.
  • Li O; Molecular Medicine Research Center, West China Hospital, Sichuan University, Chengdu 610041, China.
  • Guo R; Department of Clinical Laboratory Medicine, Xijing Hospital, the Fourth Military Medical University, Xi'an, Shanxi 710032, China.
  • Carter H; Moores Cancer Center and Institute for Genomic Medicine, University of California, San Diego, La Jolla, California 92093, USA.
  • Zhu JK; Moores Cancer Center and Institute for Genomic Medicine, University of California, San Diego, La Jolla, California 92093, USA.
  • Hao X; Moores Cancer Center and Institute for Genomic Medicine, University of California, San Diego, La Jolla, California 92093, USA.
  • Zhang K; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.
Nat Mater ; 16(11): 1155-1161, 2017 11.
Article en En | MEDLINE | ID: mdl-29035356
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Biomarcadores de Tumor / Carcinoma Hepatocelular / Metilación de ADN / ADN Tumoral Circulante / Neoplasias Hepáticas / Modelos Biológicos Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Límite: Female / Humans / Male Idioma: En Revista: Nat Mater Asunto de la revista: CIENCIA / QUIMICA Año: 2017 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Biomarcadores de Tumor / Carcinoma Hepatocelular / Metilación de ADN / ADN Tumoral Circulante / Neoplasias Hepáticas / Modelos Biológicos Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Límite: Female / Humans / Male Idioma: En Revista: Nat Mater Asunto de la revista: CIENCIA / QUIMICA Año: 2017 Tipo del documento: Article País de afiliación: China